Skip to content

Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia

Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02652533
Enrollment
41
Registered
2016-01-12
Start date
2016-09-30
Completion date
2019-07-31
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Atresia

Brief summary

The investigators plan to investigate the use of US shear wave elastography (SWE), a newly available imaging technology, in children with suspected/known BA.

Detailed description

The investigators plan a prospective, multi-center study to determine if liver ultrasound shear wave speed measurements acquired at clinical presentation can discriminate biliary atresia (BA) from other causes of liver disease in the setting of neonatal cholestasis. The investigators also plan to determine if liver ultrasound shear wave speed measurements acquired at clinical presentation or longitudinally during the first one-year period after Kasai can predict important long-term outcomes in BA patients.

Interventions

The investigators have recently published a very small study in neonates/infants with suspected BA showing that US liver shear wave speed (i.e. - liver stiffness) can differentiate BA from other causes of cholestasis, potentially with a very high degree of accuracy. Additional research is needed to confirm these very preliminary results and determine if liver shear wave speed measurements either before or after (including longitudinally) Kasai can predict key outcomes.

Sponsors

Siemens Medical Solutions
CollaboratorINDUSTRY
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Months
Healthy volunteers
No

Inclusion criteria

* neonatal cholestasis with concern for BA vs. other liver disease direct bilirubin \>20% of total or ≥2 mg/dL age \<3 months

Exclusion criteria

* inability to obtain parent/guardian consent. * inability to return for follow up visits as required by the study (these patients will be included in aim 1, but will be unable to participate in aim 2). * no other

Design outcomes

Primary

MeasureTime frameDescription
Discrimination of biliary atresia from other liver diseases using ultrasound liver shear wave speed (Aim 1)2 yearsThe primary outcome measure will be ultrasound shear wave speed of the liver. The investigators will compare the mean liver shear wave speed measurements in children with biliary atresia to other liver diseases. Sensitivity and specificity of ultrasound for diagnosing biliary atresia will be determined using multiple shear wave speed cut-off values.

Secondary

MeasureTime frameDescription
Predicting long term clinical outcomes in biliary atresia patients using ultrasound liver shear wave speed (aim 2)6 yearsChange in shear speed liver over time will be compared between children with biliary atresia versus other liver diseases in order to determine if differences predict important clinical outcomes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026